4.6 Review

Dendritic cells during Epstein Barr virus infection

期刊

FRONTIERS IN MICROBIOLOGY
卷 5, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2014.00308

关键词

plasmacytoid dendritic cells; conventional dendritic cells; monocyte-derived dendritic cells; natural killer cells; T cells

资金

  1. Cancer Research Switzerland [KFS-3234-08-2013]
  2. Association for International Cancer Research [11-0516]
  3. KFSPMS
  4. KFSPHLD of the University of Zurich
  5. University of Zurich
  6. Baugarten Foundation
  7. Sobek Foundation
  8. Fondation Acteria
  9. Wellcome Trust
  10. Leukaemia and Lymphoma Research
  11. Medical Research Council
  12. Swiss National Science Foundation [310030_143979, CRSII3_136241]
  13. Swiss National Science Foundation (SNF) [310030_143979] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Epstein Barr virus (EBV) causes persistent infection in more than 90% of the human adult population and is associated with 2% of all tumors in humans. This gamma-herpes virus infects primarily human B and epithelial cells,but it has been reported to be sensed by dendritic cells (DCs) during primary infection. These activated DCs are thought to contribute to innate restriction of EBV infection and initiate EBV-specific adaptive immune responses via cross-priming. The respective evidence and their potential importance for EBV-specific vaccine development will be discussed in this review.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据